A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial):study protocol for a randomised controlled trial

Salaminios, George, Duffy, Larisa, Ades, Anthony E et al. (23 more authors) (2017) A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial):study protocol for a randomised controlled trial. Trials. 496. ISSN 1745-6215

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© The Author(s). 2017.

Keywords: Adolescent,Adult,Affect,Aged,Antidepressive Agents,Clinical Protocols,Depression,Double-Blind Method,England,Female,Humans,Male,Mental Health,Middle Aged,Patient Health Questionnaire,Quality of Life,Research Design,Serotonin Uptake Inhibitors,Sertraline,Severity of Illness Index,Time Factors,Treatment Outcome,Young Adult,Journal Article,Multicenter Study,Randomized Controlled Trial
Dates:
  • Published: 24 October 2017
  • Accepted: 22 September 2017
Institution: The University of York
Academic Units: The University of York > Faculty of Social Sciences (York) > Centre for Reviews and Dissemination (York)
The University of York > Faculty of Sciences (York) > Hull York Medical School (York)
Depositing User: Pure (York)
Date Deposited: 19 Jul 2018 13:30
Last Modified: 16 Oct 2024 14:56
Published Version: https://doi.org/10.1186/s13063-017-2253-4
Status: Published
Refereed: Yes
Identification Number: 10.1186/s13063-017-2253-4
Open Archives Initiative ID (OAI ID):

Download

Filename: s13063_017_2253_4.pdf

Description: s13063-017-2253-4

Licence: CC-BY 2.5

Export

Statistics